Загрузка...
Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review
Edoxaban, an oral direct inhibitor of factor Xa, was recently approved in the United States and Japan for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and for treatment of venous thromboembolism (VTE). It is also licensed in Japan for prevention of VTE...
Сохранить в:
| Опубликовано в: : | J Thromb Thrombolysis |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4608015/ https://ncbi.nlm.nih.gov/pubmed/25669624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-015-1185-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|